C54.8
Malignant neoplasm of overlapping sites of corpus uteri
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of overlapping sites of the corpus uteri, classified under ICD-10 code C54.8, refers to a form of cancer that occurs in the main body of the uterus, also known as the corpus uteri. This cancer involves areas that are adjacent or overlapping within the uterine body, making accurate diagnosis and treatment essential for optimal outcomes. The corpus uteri is part of the female reproductive system and plays a central role in menstruation and pregnancy. When cancer develops here, it can impact a woman's health significantly, requiring timely medical attention and comprehensive care.
Causes & Symptoms
Clinical Causes: Hormonal imbalances, particularly excess estrogen exposure Genetic factors and family history of uterine or other gynecologic cancers Obesity, which can increase estrogen levels Reproductive history, including late menopause or few pregnancies History of tamoxifen use or other hormone-related treatments Age, with increased risk as women get older Certain hereditary syndromes, such as Lynch syndrome Chronic endometrial inflammation or hyperplasia
Key Symptoms: Abnormal uterine bleeding, especially bleeding between periods or after menopause Pelvic pain or discomfort Pelvic pressure or a sense of fullness Unusual vaginal discharge Pain during intercourse Unexplained weight loss or fatigue in advanced cases
Diagnostic & Treatment
Diagnosis Path: Pelvic examination to assess the uterus and surrounding structures Imaging studies such as ultrasound, MRI, or CT scans to visualize uterine abnormalities Endometrial biopsy to collect tissue samples for microscopic examination Hysteroscopy, which allows direct visualization and biopsy of the uterine lining Laboratory tests to evaluate overall health and blood counts Staging procedures to determine the extent of spread, which may include additional imaging or surgical exploration
Treatment Protocols: Surgical removal of the uterus (hysterectomy) and nearby tissues or lymph nodes Radiation therapy to target residual cancer cells in the uterine area Chemotherapy, especially if the cancer has spread beyond the uterus Hormone therapy to block estrogen stimulation if applicable Targeted therapies and immunotherapy in select cases Follow-up care to monitor for recurrence and manage side effects of treatment
Clinical Advice & FAQs
Billing Guidance
Is C54.8 a billable ICD-10 code?
Yes, C54.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C54.8?
Clinical documentation must specify the nature of Malignant neoplasm of overlapping sites of corpus uteri and any associated comorbidities for accurate reporting.
Cite this Clinical Reference